Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/17621
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHasan, R.en_US
dc.contributor.authorWijesinghe, J.A.A.S.en_US
dc.date.accessioned2017-09-27T04:53:37Zen_US
dc.date.available2017-09-27T04:53:37Zen_US
dc.date.issued2016en_US
dc.identifier.citationJournal of Medical and Dental Science Research.2016; 3(9): 32-33en_US
dc.identifier.issn2394-076X (Electronic)en_US
dc.identifier.issn2394-0751 (Print)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/17621
dc.description.abstractINTRODUCTION: A significant proportion of male population suffer from Male Factor Infertility (MFI) due to prolactin abnormalities. OBJECTIVE: To establish the role of prolactin on the male reproductive system. METHODOLOGY: A case control study was carried out to determine the effects of prolactin abnormalities in otherwise normal 297 males with infertility after obtaining an informed written consent. Each of the participants was subjected to a Basic Seminal Fluid Analysis(BSA) and an endocrine profile (Follicular Stimulating Hormone, Luteinizing Hormone, Testosterone and Prolactin levels). An age, Sex, height and weight matched voluntary control group was recruited for comparison. None of the cases had any medical or surgical disorder or occupational hazardous exposure which related to infertility. RESULTS: Among the controls mean age 33.2 years+/-5.2, body mass index 21.4+/- 1.39Kgm-2, sperm count 34 x 106, number of children fathered 2+/-1, Serum prolactin level 6.78+/- 2.92mg/ml. Of the case group 28/297 were hyperprolactinemic while 1/297 was hypoprolactinaemia. All the hyperprolactinemic patients had oligospermia, abnormal morphology of sperms, with reduced viability of the sperms. 26/28 Subjects with hyperprolactinaemia had markedly low testosterone levels. The only subject with hypoprolactinaemia had normal testosterone levels. FSH and LH levels were normal in all the participants. 29 subjects with abnormal prolactin levels were followed up for 12 months. 28 patients with hyperprolactinaemia were given oral bromocriptine (2.5mg twice daily). The response with bromocriptine was assessed with repeated Basic Semen Analysis. After 3 months of therapy 19/29 cases showed an improved response to the drug while 4/28 responded after 6 months of treatment. 1/28 took 1 year to show a response. 2 of the cases showed some improvement which fell short of normal BSA parameters. CONCLUSIONS: Prolactin abnormalities affects male reproductive system and semen parameters. Further studies should be carried out to find the exact mechanism of prolactin on the male reproductive system.en_US
dc.language.isoen_USen_US
dc.publisherQuest Journals Inc.en_US
dc.subjectProlactinen_US
dc.subject.meshProlactin-analysisen
dc.subject.meshInfertility, Maleen_US
dc.subject.meshInfertility, Male-diagnosisen_US
dc.subject.meshSemen Analysisen_US
dc.subject.meshRatsen
dc.titleImplications of prolactin abnormalities on the male reproductive tract and male factor infertilityen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
Hasan-2016-393233.pdf153.88 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.